Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic Frequency

IDEXX Laboratories reported strong Q1 2026 results with EPS of $3.47 (beating consensus of $3.41) and sales of $1.14 billion (above consensus of $1.109 billion), driven by higher clinical visits and diagnostic frequency. The company raised its full-year 2026 guidance for both earnings ($14.45-$14.90 vs. previous $14.29-$14.80) and sales ($4.675-$4.76 billion vs. previous $4.63-$4.72 billion). Shares were up 3.35% in premarket trading.

05/05/2026, 10:20 AM • Benzinga

Veterinary Reference Laboratory Market Size to Reach USD 13.93 Billion by 2035 with 8.58% CAGR – SNS Insider

The global veterinary reference laboratory market is projected to grow from USD 6.12 billion in 2025 to USD 13.93 billion by 2035, driven by rising pet ownership, pet humanization trends, and increased demand for advanced diagnostics. However, high infrastructure costs and shortage of skilled specialists pose challenges to market expansion.

02/17/2026, 6:00 AM • GlobeNewswire

Why Is IDEXX Labs Stock Falling Today?

IDEXX Laboratories reported better-than-expected Q4 2025 earnings of $3.08 per share (beating $2.94 consensus) with $1.091 billion in sales (beating $1.073 billion consensus) and strong growth across segments. The company issued 2026 guidance of $14.29-$14.80 EPS and $4.632-$4.720 billion in sales. Despite the positive results and strong innovation pipeline, IDEXX shares fell 5.57% to $633.10, likely due to guidance slightly below consensus expectations and ongoing end-market visit weakness concerns.

02/02/2026, 1:05 PM • Benzinga

Why Idexx Laboratories Stock Surged by Almost 15% Today

Idexx Laboratories reported strong Q3 2025 financial results, with revenue growing 13% to $1.11 billion and net income rising 18%. The company beat analyst expectations and raised its full-year guidance, leading to a significant stock price increase.

11/03/2025, 6:12 PM • The Motley Fool

Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?

Wall Street opened mixed on Monday, with AI-driven mega-cap stocks rallying while broader markets remained cautious. Nvidia and Amazon saw significant gains, while cryptocurrencies experienced notable declines.

11/03/2025, 1:01 PM • Benzinga

These Were the 5 Top-Performing Stocks in the S&P 500 in August 2025

Five S&P 500 stocks outperformed in August 2025, including Albemarle, UnitedHealth Group, Intel, Humana, and Idexx Laboratories, each with unique factors driving their stock price increases.

09/04/2025, 4:10 AM • The Motley Fool

Veterinary Oncology Market Shares, Competition and Trends Analysis 2025-2030: Discover the Impact of Advanced Therapies and Digital Tools

The veterinary oncology market is projected to grow from $1.84 billion in 2025 to $3.55 billion by 2030, driven by technological advances, rising pet ownership, and increasing demand for advanced cancer treatments in veterinary medicine.

09/03/2025, 4:41 AM • GlobeNewswire

IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation

IDEXX Laboratories reported strong Q2 2025 earnings, with $3.50 per share beating estimates and revenue rising 11% to $1.11 billion, driven by robust Companion Animal Group sales. The company raised full-year guidance, reflecting strong performance in pet healthcare.

08/04/2025, 10:45 AM • Benzinga

Veterinary practice management software market to grow at a CAGR of 8% during the forecast period (2025 – 2030): Wissen Research

The global veterinary practice management software market is projected to grow from $818 million in 2024 to $1.3 billion by 2030, with an 8% CAGR, driven by rising pet ownership, digital transformation, and increasing animal health expenditure.

07/30/2025, 5:00 PM • GlobeNewswire